INNOVATE Corp. (VATE)
NYSE: VATE · Real-Time Price · USD
8.12
+0.38 (4.91%)
Jul 30, 2026, 4:00 PM EDT - Market closed
INNOVATE Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,337 | 1,246 | 1,107 | 1,423 | 1,637 | 1,205 |
Revenue Growth | 25.37% | 12.55% | -22.20% | -13.09% | 35.85% | 68.11% |
Gross Profit Gross Profit Growth | 207.7 | 199.7 | 208.8 | 216 | 221.4 | 183.7 |
Operating Income Operating Income Growth | 35.3 | 28.7 | 40 | 26.5 | 13.4 | -10.6 |
Net Income Net Income Growth | -56.4 | -64 | -35.8 | -37.6 | -40.8 | -229.7 |
Earnings Per Share EPS Growth | -4.25 | -4.84 | -3.08 | -4.81 | -5.30 | -10.50 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Spectrum Spectrum Growth | 22.3 | 23.2 | 25.7 | 22.5 | 38.7 | 42 |
Life Sciences Life Sciences Growth | 11 | 12.5 | 9.8 | 3.3 | 4.3 | 3.5 |
Infrastructure Infrastructure Growth | 1,303 | 1,210 | 1,072 | 1,397 | 1,594 | 1,160 |
Total Total Growth | 1,337 | 1,246 | 1,107 | 1,423 | 1,637 | 1,205 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 134.6 | 112.1 | 48.8 | 80.8 | 80.4 | 45.5 |
Total Debt Total Debt Growth | 679.6 | 661.7 | 662.8 | 709.8 | 714.4 | 626.3 |
Net Cash (Debt) Net Cash Growth | -545 | -549.6 | -614 | -629 | -634 | -580.8 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -41.07 | -41.58 | -57.40 | -80.47 | -81.81 | -75.33 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 206.2 | 146.6 | 9.1 | 26.5 | -9.5 | 54 |
Capital Expenditures CapEx Growth | -30.9 | -26.1 | -19 | -18.4 | -20.7 | -24.1 |
Free Cash Flow Free Cash Flow Growth | 175.3 | 120.5 | -9.9 | 8.1 | -30.2 | 29.9 |
Free Cash Flow Growth | 7521.74% | - | - | - | - | -53.57% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 15.54% | 16.03% | 18.86% | 15.18% | 13.52% | 15.24% |
Operating Margin | 2.64% | 2.30% | 3.61% | 1.86% | 0.82% | -0.88% |
Pretax Margin | -4.26% | -4.94% | -3.02% | -2.42% | -2.51% | -6.70% |
Profit Margin | -4.05% | -5.14% | -3.59% | -2.73% | -2.57% | -7.16% |
FCF Margin | 13.12% | 9.67% | -0.89% | 0.57% | -1.84% | 2.48% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Yield | 3.68% | 2.27% | 2.29% | 0.48% | 1.02% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 5.19 | 5.19 | 5.19 | 5.19 | 5.19 |
P/FCF Ratio | 0.63 | 0.51 | - | 12.03 | - | 9.63 |
PS Ratio | 0.08 | 0.05 | 0.06 | 0.07 | 0.09 | 0.24 |